menu search

23andme stock rallies more than 23% after genetics company gets ok to report more cancer risks

Shares of 23andMe Holding Co. ME, -4.35% jumped 23% in the extended session Thursday after the genetics...

August 31, 2023, 5:49 pm

23andme granted new fda clearance to report additional brca variants

510(k) clearance will allow 23andMe to report an additional 41 genetic variants in the BRCA1 and BRCA2 ...

August 31, 2023, 5:28 pm

Beam therapeutics to participate in upcoming september investor conferences

CAMBRIDGE, Mass., Aug. 31, 2023 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision g...

August 31, 2023, 10:30 am

Genetic insights propel dyslexia treatment market driven to us$ 8008.9 million by 2033, to surge at 6.3% cagr | future market insights, inc.

The study outlines the scope and content of the research, covering driving factors, market size, and forecast data for dyslexia treatment. The researc...

August 31, 2023, 1:30 am

Adaptive biotechnologies to participate in the morgan stanley 21st annual global healthcare conference

SEATTLE, Aug. 30, 2023 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage b...

August 30, 2023, 8:30 pm

Reneo pharmaceuticals to participate in upcoming investor conferences

IRVINE, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the ...

August 29, 2023, 11:35 am

Arbor biotechnologies appoints ajim tamboli as chief financial officer

CAMBRIDGE, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) — Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation o...

August 29, 2023, 11:00 am

Praxis precision medicines to present analyses of patient-focused, clinically meaningful endpoints from essential1 study of ulixacaltamide in essential tremor at the 2023 mds international congress

BOSTON, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating g...

August 28, 2023, 7:00 am

The gmo frontier: 3 synthetic biology stocks for your must-buy list

It's been more than a half century since humanity first learned to genetically modify organisms. While ...

August 25, 2023, 5:11 pm

Bridgebio pharma to present detailed results from the phase 3 attribute study in patients with transthyretin amyloidosis cardiomyopathy (attr-cm) at european society of cardiology (esc) congress 2023

PALO ALTO, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage...

August 24, 2023, 4:01 pm

Thermo fisher (tmo) launches new chromosomal microarray

Thermo Fisher's (TMO) CytoScan HD Accel array can save labs weeks or even months by accelerating the time it takes to get findings from cytog...

August 23, 2023, 12:02 pm

Rare neurodegenerative disease treatment market to cross us$ 119.2 billion valuation by 2033 | fact.mr report

Advances in Genetic Research and Personalized Medicine is a key driver which is helping to shape the Ra...

August 23, 2023, 9:00 am

Genedx announces data demonstrating that whole exome and genome sequencing report fewer variants of uncertain significance (vus) than multi-gene panel testing published in genetics in medicine

STAMFORD, Conn., Aug. 21, 2023 (GLOBE NEWSWIRE) — GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, tod...

August 21, 2023, 11:00 am

Krystal biotech announces sale of priority review voucher for $100 million

PITTSBURGH, Aug. 21, 2023 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (NASDAQ: KRYS) (the “Company”), a commercial-stage biotechnology company focu...

August 21, 2023, 11:00 am

Exel or ilmn: which is the better value stock right now?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Exelixis (EXE...

August 18, 2023, 1:19 pm

Agios pharmaceuticals: positive phase 2 results in sickle cell study

Agios Pharmaceuticals is a biotech company focused on developing medicines for cancer and rare genetic ...

August 17, 2023, 5:14 am

Myriad genetics (mygn) adds arr to prolaris biomarker test

Myriad Genetics (MYGN) announces the integration of ARR into the Prolaris prostate cancer prognostic te...

August 16, 2023, 10:14 am

Myriad genetics advances prostate cancer care with addition of absolute risk reduction to prolaris®

Prolaris is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiation therapy1 SALT LAKE CITY, Aug. 15, 202...

August 15, 2023, 11:05 am

Design therapeutics stock plunges on trial results for neuromuscular disease treatment

Shares of Design Therapeutics Inc. DSGN dropped 45% in premarket trading Tuesday after the biopharma company reported mixed results from an early-stag...

August 15, 2023, 8:17 am

Sophia genetics sa (soph) q2 2023 earnings call transcript

SOPHiA GenetiCS SA (NASDAQ:SOPH ) Q2 2023 Earnings Conference Call August 8, 2023 8:30 AM ET Company Pa...

August 12, 2023, 12:24 pm


Search within

Pages Search Results: